The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Gut–Liver Axis in Alcoholic Liver Disease
Open accessAbstract
Alcoholic liver disease (ALD) has been among the leading causes of cirrhosis and liver-related death worldwide for decades. Early discoveries in alcoholic liver disease identified increased levels of bacterial endotoxin in the portal circulation, suggesting a role for gut-derived toxins in ALD. Indeed, alcohol consumption can disrupt the intestinal epithelial barrier and result in increased gut permeability that increasingly is recognized as a major factor in ALD. Bacterial endotoxin, lipopolysaccharide, is a prototypic microbe-derived inflammatory signal that contributes to inflammation in ALD through activation of the Toll-like receptor 4. Recent studies also have shown that alcohol consumption is associated with alterations in the gut microbiome, and the dysbalance of pathogenic and commensal organisms in the intestinal microbiome may contribute to the abnormal gut-liver axis in ALD. Indeed, bacterial decontamination improves ALD both in human and animal models. This short review summarizes recent findings and highlights emerging trends in the gut-liver axis relevant to ALD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“the gut-liver axis has been shown to play an important role in the development of ALD.5,6”
From Opposite regulation of intestinal and intrahepatic CD8 + T cells controls alcohol-associated liver disease progression (2025) · cites this paper as [6]
Experimental — accuracy not yet measuredIn the citing paper
“A number of functional studies have shown a key contribution of the gut-microbiota–TLR4 axis to ALD45:”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,820
CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Wright, S. D., Ramos, R., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,986
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Baumann, H., & Gauldie, J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90137-6 · Cited by 2,907
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
The Liver as an Immunological Organ
Racanelli, V., & Rehermann, B. (2006) · Hepatology · doi:10.1002/hep.21060 · Cited by 1,377
Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
Dapito, D. H., Mencin, A., Gwak, G.-Y., Pradere, J.-P., Jang, M.-K., Mederacke, I., Caviglia, J. M., Khiabanian, H., Adeyemi, A., Bataller, R., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.007 · Cited by 1,346
Bile acids and the gut microbiome
Ridlon, J. M., Kang, D. J., Hylemon, P. B., & Bajaj, J. S. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000057 · Cited by 1,329
Rifaximin Treatment in Hepatic Encephalopathy
Bass, N. M., Mullen, K. D., Sanyal, A., Poordad, F., Neff, G., Leevy, C. B., Sigal, S., Sheikh, M. Y., Beavers, K., Frederick, T., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907893 · Cited by 1,300
Interactions Between the Intestinal Microbiome and Liver Diseases
Schnabl, B., & Brenner, D. A. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.020 · Cited by 971
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 754
Ambade, A., Satishchandran, A., & Szabó, G. (2016) · Scientific Reports · doi:10.1038/srep21340 · Cited by 85
Yang, X., He, F., Zhang, Y.-T. Y., Xue, J., Li, K., Zhang, X., Zhu, L., Wang, Z., Wang, H., & Yang, S. (2018) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13950 · Cited by 85
Wang, K., Yang, X., Wu, Z.-J., Wang, H., Li, Q., Mei, H., You, R., & Zhang, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00240 · Cited by 85
Svendsen, P., Graversen, J. H., Etzerodt, A., Hager, H., Røge, R., Grønbæk, H., Christensen, E. I., Møller, H. J., Vilstrup, H., & Moestrup, S. K. (2017) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2016.11.004 · Cited by 84
Choi, Y., Abdelmegeed, M. A., & Song, B. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.11.011 · Cited by 83
Kim, W.-G., Kim, H. I., Kwon, E. K., Han, M. J., & Kim, D. (2018) · Food & Function · doi:10.1039/c8fo00252e · Cited by 83
Porcine models for studying complications and organ crosstalk in diabetes mellitus
Renner, S., Blutke, A., Clauß, S., Deeg, C. A., Kemter, E., Merkus, D., Wanke, R., & Wolf, E. (2020) · Cell and Tissue Research · doi:10.1007/s00441-019-03158-9 · Cited by 94
Gut–liver axis and sterile signals in the development of alcoholic liver disease
Szabó, G., & Petrášek, J. (2017) · Alcohol and Alcoholism · doi:10.1093/alcalc/agx025 · Cited by 85
Perfluorooctanoic acid-induced liver injury is potentially associated with gut microbiota dysbiosis
Wang, G., Pan, R., Liang, X., Wu, X., Wu, Y., Zhang, H., Zhao, J., & Chen, W. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2020.129004 · Cited by 82
Terciolo, C., Dapoigny, M. C., & André, F. (2019) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s181590 · Cited by 94
Recent advances of sterile inflammation and inter-organ cross-talk in alcoholic liver disease
Shim, Y., & Jeong, W. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0438-5 · Cited by 81
Li, J., Guo, C., Liu, Y., Han, B., Lv, Z., Jiang, H., Li, S., & Zhang, Z. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.01.019 · Cited by 83
Shi, S., Wang, X., van der Laan, L. J. W., Pan, Q., & Verstegen, M. M. A. (2021) · Transplantation · doi:10.1097/tp.0000000000003691 · Cited by 85
Gut microbiota: A magical multifunctional target regulated by medicine food homology species
Zuo, W., Pang, Q., Yao, L.-P., Zhang, Y., Peng, C. Y., Huang, W., & Han, B. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.05.011 · Cited by 81
Inflammatory status in human hepatic cirrhosis
Martinez‐Esparza, M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i41.11522 · Cited by 80
Candida albicans and candidalysin in inflammatory disorders and cancer
Ho, J., Camilli, G., Griffiths, J. S., Richardson, J. P., Kichik, N., & Naglik, J. R. (2020) · Immunology · doi:10.1111/imm.13255 · Cited by 82
Mima, K., Ogino, S., Nakagawa, S., Sawayama, H., Kinoshita, K., Krashima, R., Ishimoto, T., Imai, K., Iwatsuki, M., Hashimoto, D., et al. (2017) · Surgical Oncology · doi:10.1016/j.suronc.2017.07.011 · Cited by 80
Bile Acid Signaling in Metabolic and Inflammatory Diseases and Drug Development
Li, T., & Chiang, J. Y. L. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.000978 · Cited by 85
Immunoglobulin A and liver diseases
Inamine, T., & Schnabl, B. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-017-1400-8 · Cited by 76
Hwang, B. B., Chang, M. H., Lee, J. H., Heo, W., Kim, J. K., Pan, J. H., Kim, Y. J., & Kim, J. H. (2019) · Nutrients · doi:10.3390/nu11040857 · Cited by 78
Lei, C., Sun, R., Xu, G., Tan, Y. H., Feng, W., McClain, C. J., & Deng, Z. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.09.001 · Cited by 76
Zhu, L.-R., Li, S., Zheng, W.-Q., Ni, W., Cai, M., & Liu, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1086078 · Cited by 80
Israelsen, M. E., Madsen, B. S., Torp, N., Johansen, S., Hansen, C. D., Detlefsen, S., Andersen, P., Hansen, J. K., Lindvig, K. P., Rasmussen, D. N., et al. (2023) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(23)00010-9 · Cited by 78
Kirpich, I., McClain, C. J., Vatsalya, V., Schwandt, M. L., Phillips, M. J., Falkner, K. C., Zhang, L., Harwell, C., George, D. T., & Umhau, J. C. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13346 · Cited by 74
Alcohol and Obesity: A Dangerous Association for Fatty Liver Disease
Mahli, A., & Hellerbrand, C. (2016) · Digestive Diseases · doi:10.1159/000447279 · Cited by 73
Stadlbauer, V., Horvath, A., Komarova, I., Schmerboeck, B., Feldbacher, N., Wurm, S., Klymiuk, I., Durdević, M., Rainer, F., Blesl, A., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211703 · Cited by 72
Chen, J., Xuan, Y.-H., Luo, M.-X., Ni, X.-G., Ling, L.-Q., Hu, S.-J., Chen, J.-Q., Xu, J., Jiang, L., Si, W.-Z., et al. (2019) · Toxicology · doi:10.1016/j.tox.2019.152338 · Cited by 71
Arab, J. P., Arrese, M. A., & Shah, V. H. (2019) · Hepatology Research · doi:10.1111/hepr.13473 · Cited by 76
Xia, T., Zhang, B., Li, S., Fang, B., Duan, W., Zhang, J., Song, J. M., & Wang, M. (2020) · Food & Function · doi:10.1039/c9fo03015h · Cited by 71
Li, Q., Liu, W., Feng, Y., Hou, H., Zhang, Z., Yu, Q., Zhou, Y., Luo, Q., Luo, Y., Ouyang, H., et al. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.04.067 · Cited by 70
Gerges, S. H., Wahdan, S. A., Elsherbiny, D. A., & El‐Demerdash, E. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119220 · Cited by 76
Wu, Y., Wang, B., Tang, L., Zhou, Y., Wang, Q., Gong, L., Ni, J., & Li, W. (2022) · Antioxidants · doi:10.3390/antiox11020291 · Cited by 71
Zou, B., Li, J., Ma, R., Cheng, X.-Y., Ma, R.-Y., Zhou, T.-Y., Wu, Z., Yao, Y., & Li, J. (2023) · Aging and Disease · doi:10.14336/ad.2022.1127 · Cited by 76
The gut–liver axis in immune remodeling of hepatic cirrhosis
Guan, H., Zhang, X., Kuang, M., & Yu, J. Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.946628 · Cited by 73
Yang, K., & Song, M. J. (2023) · Nutrients · doi:10.3390/nu15183970 · Cited by 73
Cho, Y., Song, B., Akbar, M. D., & Baek, M. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.03.009 · Cited by 70
Li, X., Liu, Y., Guo, X., Ma, Y., Zhang, H., & Liang, H. W. (2021) · European Journal of Clinical Nutrition · doi:10.1038/s41430-020-00852-8 · Cited by 68
Mechanistic understanding of β-cryptoxanthin and lycopene in cancer prevention in animal models
Lim, J. Y., & Wang, X. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158652 · Cited by 70
Li, S., Wang, N., Tan, H., Chueng, F., Zhang, Z., Yuen, M., & Feng, Y. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.112 · Cited by 66
Ballway, J. W., & Song, B.-J. (2021) · Antioxidants · doi:10.3390/antiox10030384 · Cited by 72
Ji, G., Ma, L., Yao, H., Ma, S., Si, X., Wang, Y., Bao, X., Ma, L., Chen, F., Ma, C., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.09.004 · Cited by 65
Alcohol Use As a Risk Factor in Infections and Healing: A Clinician's Perspective
Trevejo-Nuñez, G. (2015) · Alcohol research · doi:10.35946/arcr.v37.2.03 · Cited by 65
Zhang, Y., Jin, Q., Li, X., Jiang, M., Cui, B., Xia, K., Wu, Y., Lian, L., & Nan, J. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b00944 · Cited by 66
Intestinal microbiome as a novel therapeutic target for local and systemic inflammation
Uchiyama, K., Naito, Y., & Takagi, T. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.03.006 · Cited by 65
Liver as a target of human immunodeficiency virus infection
Ganesan, M., Poluektova, L. Y., Kharbanda, K. K., & Osna, N. A. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i42.4728 · Cited by 67
Jantararussamee, C., Rodniem, S., Taweechotipatr, M., Showpittapornchai, U., & Pradidarcheep, W. (2020) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-020-09663-6 · Cited by 64
Zhang, N., Hu, Y. W., Ding, C., Zeng, W., Shan, W., Fan, H. J., Zhao, Y., Shi, X., Gao, L., Xu, T., et al. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.12.010 · Cited by 64
Iracheta‐Vellve, A., Petrášek, J., Gyogyosi, B., Bala, S., Csák, T., Kodys, K., & Szabó, G. (2017) · Liver International · doi:10.1111/liv.13430 · Cited by 64
Okushin, K., Tsutsumi, T., Enooku, K., Fujinaga, H., Kado, A., Shibahara, J., Fukayama, M., Moriya, K., Yotsuyanagi, H., & Koike, K. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1148-y · Cited by 64
Swanson, G. R., Gorenz, A., Shaikh, M. W., Desai, V., Kaminsky, T. J., van den Berg, J., Murphy, T. E., Raeisi, S., Fogg, L., Vitaterna, M. H., et al. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00087.2016 · Cited by 63
Current Management of Alcoholic Hepatitis and Future Therapies
Saberi, B., Dadabhai, A. S., Jang, Y.-Y., Gurakar, A. O., & Mezey, E. (2016) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2016.00006 · Cited by 65
Gut Microbiota-Derived Mediators as Potential Markers in Nonalcoholic Fatty Liver Disease
Aragonès, G., González-García, S., Aguilar, C., Richart, C., & Auguet, T. (2019) · BioMed Research International · doi:10.1155/2019/8507583 · Cited by 69
Autotaxin-lysophosphatidic acid receptor signalling regulates hepatitis C virus replication
Farquhar, M. J., Humphreys, I., Rudge, S. A., Wilson, G. K., Bhattacharya, B., Ciaccia, M., Hu, K., Zhang, Q., Mailly, L., Reynolds, G. M., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.009 · Cited by 62
Zhao, D., Xu, Y., Gu, T., Wang, H., Yin, Y., Sheng, B., Li, Y., Nian, Y., Wang, C., Li, C., et al. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b06618 · Cited by 64
Role of liver sinusoidal endothelial cell in metabolic dysfunction-associated fatty liver disease
He, Q., He, W., Dong, H., Guo, Y., Yuan, G., Shi, X., Wang, D., & Lu, F. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01720-9 · Cited by 68
Wogonin attenuates inflammation by activating PPAR-γ in alcoholic liver disease
Li, H.-D., Chen, X., Yang, Y., Huang, H., Zhang, L., Zhang, X., Zhang, L., Huang, C., Meng, X., & Li, J. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.06.013 · Cited by 61
Shah, R., Reyes‐Gordillo, K., Cheng, Y., Varatharajalu, R., Ibrahim, J., & Lakshman, M. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/9630175 · Cited by 61
Alcoholic Liver Disease: Current Mechanistic Aspects with Focus on Their Clinical Relevance
Teschke, R. (2019) · Biomedicines · doi:10.3390/biomedicines7030068 · Cited by 62
Zinc deficiency as a mediator of toxic effects of alcohol abuse
Skalny, A. V., Skalnaya, M. G., Grabeklis, A. R., Skalnaya, A. A., & Tinkov, A. A. (2018) · European Journal of Nutrition · doi:10.1007/s00394-017-1584-y · Cited by 60
Ursolic Acid Improves Intestinal Damage and Bacterial Dysbiosis in Liver Fibrosis Mice
Wan, S., Liu, C., Huang, C., Luo, F., & Zhu, X. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01321 · Cited by 60
Liu, Y., Zhang, X., Chen, S., Wang, J., Yu, S., Li, Y., Xu, M. M., Aboubacar, H., Li, J., Shan, T., et al. (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0039 · Cited by 59
Babuta, M., & Szabó, G. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mir0321-156r · Cited by 63
Shi, Y., Liu, Y., Wang, S., Huang, J., Luo, Z., Jiang, M., Lu, Y., Lin, Q., Liu, H., Cheng, N., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121720 · Cited by 58
Potential mechanisms linking gut microbiota and portal hypertension
Baffy, G. (2018) · Liver International · doi:10.1111/liv.13986 · Cited by 59
Zhong, X., Cui, P., Jiang, J., Ning, C., Liang, B., Zhou, J., Li, T., Zhang, Y., Lei, T., Zuo, T., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.649060 · Cited by 58
Rathour, D., Shah, S., Khan, S., Singh, P. K., Srivastava, S., Singh, S. B., & Khatri, D. K. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114081 · Cited by 58
Zhang, R., Yan, Z., Zhong, H., Rong, L., Liu, W., Xiong, S., Liu, Q., & Liu, M. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000484 · Cited by 57
Bukong, T. N., Iracheta‐Vellve, A., Saha, B., Ambade, A., Satishchandran, A., Gyöngyösi, B., Lowe, P., Catalano, D., Kodys, K., & Szabó, G. (2016) · Hepatology · doi:10.1002/hep.28680 · Cited by 56
Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis
Nishimura, N., Kaji, K., Kitagawa, K., Sawada, Y., Furukawa, M., Ozutsumi, T., Fujinaga, Y., Tsuji, Y., Takaya, H., Kawaratani, H., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136921 · Cited by 58
Zhu, H., Jiang, W., Liu, C., Wang, C., Hu, B., Guo, Y., Cheng, Y., & Qian, H. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175096 · Cited by 55
Role of Gut Barrier Function in the Pathogenesis of Nonalcoholic Fatty Liver Disease
Dai, X., & Wang, B. (2015) · Gastroenterology Research and Practice · doi:10.1155/2015/287348 · Cited by 55
Seo, H.-Y., Kim, M. K., Lee, S.-H., Hwang, J. S., Park, K., & Jang, B. K. (2018) · Nutrients · doi:10.3390/nu10070863 · Cited by 55
Lin, W., Yue, F., Lin, X., Wu, S., Shi, Y., Li, J., Xiang, X., Lam, S. M., Shui, G., Russell, R., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01975 · Cited by 56
Qiu, P., Dong, Y. H., Zhu, T., Luo, Y., Kang, X., Pang, M.-X., Li, H., Xu, H., Gu, C., Pan, S.-H., et al. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.09.209 · Cited by 54
Alcohol use disorder and the gut
Haber, P., & Kortt, N. C. (2020) · Addiction · doi:10.1111/add.15147 · Cited by 54
Donde, H., Ghare, S. S., Joshi‐Barve, S., Zhang, J., Vadhanam, M. V., Gobejishvili, L., Lorkiewicz, P. K., Srivastava, S., McClain, C. J., & Barve, S. S. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.10.005 · Cited by 54
Inflammation and gut microbiota in the alcoholic liver disease
Gao, Y. (2024) · Food & medicine homology. · doi:10.26599/fmh.2024.9420020 · Cited by 59
Wu, X., Yang, Y., Li, W., Cheng, Y., Li, X., Huang, C., Meng, X., Wu, B., Liu, X., Zhang, L., et al. (2016) · Scientific Reports · doi:10.1038/srep18685 · Cited by 53
Adult mouse model of early hepatocellular carcinoma promoted by alcoholic liver disease
Ambade, A., Satishchandran, A., Gyongyosi, B., Lowe, P., & Szabo, G. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i16.4091 · Cited by 52
Khan, M. Y., Mihali, A. B., Rawala, M. S., Aslam, A., & Siddiqui, W. J. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001371 · Cited by 52
Mao, J., Zhan, H., Meng, F., Wang, G., Huang, D. Y., Liao, Z., & Chen, M. (2022) · Phytotherapy Research · doi:10.1002/ptr.7383 · Cited by 51
Regulation of the NLRP3 inflammasome with natural products against chemical-induced liver injury
Zou, J., Wang, S., Wang, Y., & Wan, J. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105388 · Cited by 50
Kim, D.-H., Sim, Y., Hwang, J.-H., Kwun, I., Lim, J., Kim, J., Kim, J., Baek, M., Akbar, M. D., Seo, W., et al. (2021) · Antioxidants · doi:10.3390/antiox10091386 · Cited by 51
Han, X., Zhao, W. H., Zhou, Q., Chen, H., Yuan, J., Xiaofu, Z., & Zhang, Z. (2022) · Food & Function · doi:10.1039/d2fo00836j · Cited by 51
Intestinal Barrier Function in the Pathogenesis of Nonalcoholic Fatty Liver Disease
Liu, L., Yin, M., Gao, J., Yu, C., Lin, J., Wu, A., Zhu, J., Xu, C., & Liu, X. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00089 · Cited by 51
Microbiota-based treatments in alcoholic liver disease
Sung, H., Kim, S. W., Hong, M., & Suk, K. T. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i29.6673 · Cited by 50
Effects of High Carbohydrate Diet-Modulated Microbiota on Gut Health in Chinese Perch
Zhang, Y., Liang, X., He, S., Xu, C., Wang, J., Li, J., Zhu, Q.-S., Zhang, Z., Li, L., & Alam, M. S. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.575102 · Cited by 50
Zhu, Y., Wang, X., Zhu, L., Tu, Y., Chen, W., Gong, L., Pan, T., Lin, H., Lin, J., Sun, H., et al. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.115923 · Cited by 49
Dong, X., Suo, S., Wang, Y., Zeng, Y.-H., Chi, C., & Wang, B. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106537 · Cited by 49
Song, B., Akbar, M. D., Jo, I., Hardwick, J. P., & Abdelmegeed, M. A. (2015) · Advances in pharmacology · doi:10.1016/bs.apha.2015.04.002 · Cited by 51
Avila, D. V., Barker, D. F., Zhang, J., McClain, C. J., Barve, S. S., & Gobejishvili, L. (2016) · The Journal of Pathology · doi:10.1002/path.4760 · Cited by 49
Effects of Endotoxin on Type 3 Inositol 1,4,5‐Trisphosphate Receptor in Human Cholangiocytes
França, A., Filho, A. C. M. L., Guerra, M. T., Weerachayaphorn, J., dos Santos, M. L., Njei, B. M., Robert, M. E., Lima, C. X., Vidigal, P. V. T., Bañales, J. M., et al. (2018) · Hepatology · doi:10.1002/hep.30228 · Cited by 49
Wang, Z., Zhu, H., Jiang, Q. Y., & Zhu, Y. Z. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104976 · Cited by 49
Fuenzalida, C., Dufeu, M. S., Poníachik, J., Roblero, J. P., Valenzuela-Pérez, L., & Beltrán, C. J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.729950 · Cited by 51
He, L., Yao, D.-H., Wang, L., Zhang, L., & Bai, X. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.761836 · Cited by 49
NLRP3: a new therapeutic target in alcoholic liver disease
Brahadeeswaran, S., Dasgupta, T., Manickam, V., Saraswathi, V., & Tamizhselvi, R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1215333 · Cited by 51
Lee, J., Ha, J. S., Park, H.-Y., & Lee, E. (2019) · Food Research International · doi:10.1016/j.foodres.2019.108800 · Cited by 47
Wang, W., Shang, H., Li, J., Ma, Y., Xu, C., Ma, J., Hou, J., & Jiang, Z. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c06478 · Cited by 48
Alcohol-associated liver disease: Natural history, management and novel targeted therapies
Alvarado‐Tápias, E., Pose, E., Gratacós‐Ginès, J., Clemente, A. P. G., López‐Pelayo, H., & Bataller, R. A. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0709 · Cited by 55
Cannabis use is associated with reduced prevalence of progressive stages of alcoholic liver disease
Adejumo, A., Ajayi, T. O., Adegbala, O. M., Adejumo, K. L., Alliu, S., Akinjero, A., Onyeakusi, N. E., Ojelabi, O., & Bukong, T. N. (2018) · Liver International · doi:10.1111/liv.13696 · Cited by 47
Metadata
- Authors
- Szabo, G.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 148
- Issue
- 1
- Pages
- 30-36
- ISSN
- 0016-5085 (ISSN-L)
- PMC
- PMC4274189
- OpenAlex
- W2034801500
- Cited by
- 754
- References
- 81
- Citations by year
- 2026: 64 · 2025: 67 · 2024: 72 · 2023: 67 · 2022: 89 · 2021: 77 · 2020: 63 · 2019: 59 · 2018: 67 · 2017: 49 · 2016: 51 · 2015: 28
- FWCI
- 6.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (AA021907, AA017729, AA010744)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- alcoholic liver disease, gut-liver axis, bacterial endotoxin, lipopolysaccharide, intestinal permeability, intestinal epithelial barrier, TLR4, gut microbiota, bacterial decontamination, liver cirrhosis, inflammation
- MeSH terms
- Animals, Bacteria, Humans, Intestinal Mucosa, Intestines, Liver, Liver Diseases, Alcoholic, Permeability, Prognosis, Signal Transduction, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
